Status:
COMPLETED
Sensory Evaluation of Oral Nutrition Supplements in Patients at Risk for Mucositis Undergoing Cancer Treatment
Lead Sponsor:
Rutgers, The State University of New Jersey
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Esophagitis
Malignant Neoplasm
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This pilot clinical trial studies sensory evaluation of oral nutrition supplements in patients at risk for mucositis undergoing cancer treatment. Sensory evaluation may help to obtain input about new ...
Detailed Description
PRIMARY OBJECTIVES: I. To identify two products (one from the creamy shake category and one from the tea category) with the highest total average score that will be selected to move onto further test...
Eligibility Criteria
Inclusion
- Undergoing cancer treatment (chemotherapy, radiotherapy, and/or immunotherapy)
- At risk for mucositis OR with stage I mucositis or esophagitis (i.e. radiotherapy to the head, neck, esophagus or lung OR treatment with fluorouracil (5-FU) or other chemotherapeutic agents that are known to cause mucositis or esophagitis) or at risk for xerostomia
- Within the first 3 weeks of initiation of a new type of therapy
- Able to read and write in English
- Able to provide written informed consent
Exclusion
- Food allergy to any component of the supplement
- Inability to taste or smell due to medication or health condition
Key Trial Info
Start Date :
July 25 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 31 2017
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03228147
Start Date
July 25 2017
End Date
October 31 2017
Last Update
November 17 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, United States, 08903